Xue Pan
Suzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Chemotherapy combined with tislelizumab for a male patient with primary pulmonary choriocarcinoma: a case report and literature review.
Journal: Discover oncology
Published: September 12, 2025
LINC01314 suppresses proliferation and invasion via epithelial-to-mesenchymal transition regulation in lung adenocarcinoma.
Journal: Translational cancer research
Published: April 25, 2025
Corrigendum to "Characterization and verification of CD81 as a potential target in lung squamous cell carcinoma" [Biochem. Biophys. Res. Commun. 692 (2024), 149344].
Journal: Biochemical and biophysical research communications
Published: July 07, 2024
Successful therapy of a critically ill non-small cell lung cancer patient with compound mutations in EGFR G719X and S768I genes using furmonertinib: A case report.
Journal: Heliyon
Published: December 04, 2023
Characterization and verification of CD81 as a potential target in lung squamous cell carcinoma.
Journal: Biochemical and biophysical research communications
Published: November 23, 2023
Nomogram for predicting 90-day mortality in patients with Acinetobacter baumannii-caused hospital-acquired and ventilator-associated pneumonia in the respiratory intensive care unit.
Journal: The Journal of international medical research
Published: March 20, 2023
POLRMT over-expression is linked to WNT/beta-catenin signaling, immune infiltration, and unfavorable outcomes in lung adenocarcinoma patients.
Journal: Cancer medicine
Published: November 09, 2022
Bioinformatics Analysis of Prognosis-Related Genes and Expression of CXCL8 in Colorectal Cancer.
Journal: BioMed research international
Published: May 02, 2022
A novel GHR-ALK fusion gene in a patient with metastatic lung adenocarcinoma and its response to crizotinib: a case report.
Journal: The Journal of international medical research
Published: September 30, 2021
FUCA2 Is a Prognostic Biomarker and Correlated With an Immunosuppressive Microenvironment in Pan-Cancer.
Journal: Frontiers in immunology
Published: August 14, 2021
Prognostic value of programmed cell death-ligand 1 expression in patients with non-small-cell lung cancer: evidence from an updated meta-analysis.
Journal: OncoTargets and therapy
Published: December 15, 2015
Last Updated: 09/26/2026